U.S. Stock News

NasdaqGS:LSTR
NasdaqGS:LSTRTransportation

How Investors May Respond To Landstar System (LSTR) Earnings Beat And Dividend Hike

Landstar System, Inc. recently reported past second-quarter 2026 results showing sales of US$1,411.38 million and net income of US$48.95 million, alongside a 10% increase in its quarterly dividend to US$0.44 per share. The combination of higher revenue and earnings over both the quarter and first half of 2026, together with a higher dividend, underlines management’s confidence in the business and its ongoing focus on returning cash to shareholders. With this earnings improvement and dividend...
NYSE:CNO
NYSE:CNOInsurance

3% Overvalued? CNO Financial Group (CNO) Following Its Dividend And Guidance Update

CNO Financial Group (CNO) has drawn fresh attention after affirming a quarterly cash dividend of $0.18 per share, along with its recent earnings report, upgraded full year guidance and continued share repurchases. See our latest analysis for CNO Financial Group. The recent dividend affirmation and guidance upgrade come after a strong run in CNO Financial Group's stock, with a 90 day share price return of 19.47% and a 1 year total shareholder return of 51.43% that point to strengthening...
NasdaqGS:SBAC
NasdaqGS:SBACSpecialized REITs

Is SBA Communications (SBAC) Undervalued Following Its Earnings And Guidance Update?

SBA Communications (SBAC) has released a busy August update, combining its second quarter and six-month results with refreshed 2026 guidance, a quarterly dividend affirmation, and a buyback progress report. See our latest analysis for SBA Communications. The fresh earnings, guidance and dividend update arrives after a weaker share price patch, with SBA Communications posting a 90 day share price return that fell 15.29% and a 1 year total shareholder return that declined 14.71%, which signals...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

Can Praxis Precision Medicines' (PRAX) Extended Cash Runway Offset Mounting Losses In Its CNS Pipeline Push?

Praxis Precision Medicines recently reported its second-quarter 2026 results, posting a net loss of US$83.72 million and basic loss per share from continuing operations of US$2.87, while six-month losses reached US$176.28 million with a basic loss per share of US$6.08. Despite the larger losses, management highlighted continued progress on late-stage central nervous system drug candidates and reiterated that its cash resources are expected to fund operations into 2028, placing near-term...
NasdaqCM:PRCH
NasdaqCM:PRCHInsurance

Porch Group (PRCH) After Strong Q2 And Higher Guidance, Is The Valuation Case Stronger?

Porch Group (PRCH) is back in focus after a strong Q2 2026, with higher sales, positive net income, and improved Insurance Services leading management to raise full year revenue and adjusted EBITDA guidance. See our latest analysis for Porch Group. The earnings surprise and upgraded 2026 guidance appear to be feeding into stronger momentum for Porch Group, with a 30 day share price return of 6.73% and a 90 day share price return of 53.44%. That sits alongside a year to date share price return...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Why Celldex Therapeutics (CLDX) Is Up 10.7% After Wider Losses And Barzolvolimab Phase 3 Progress

Earlier this week, Celldex Therapeutics reported its second quarter 2026 results, showing revenue of just US$22,000 and a net loss of US$73.5 million, alongside a wider first-half loss of US$152.19 million. At the same time, the company updated investors on its clinical pipeline, highlighting positive Phase 1 data for bispecific antibody CDX-622 and continued progress of barzolvolimab into late-stage studies despite discontinuing a prurigo nodularis program. Next, we’ll examine how the...
NasdaqGS:IPGP
NasdaqGS:IPGPElectronic

Did IPG Photonics' (IPGP) Q2 Revenue Gain and Softer EPS, Plus New Guidance, Just Shift Its Investment Narrative?

In August 2026, IPG Photonics reported second-quarter 2026 results showing sales rising to US$278.58 million from US$250.72 million a year earlier, while net income eased to US$5.24 million and diluted earnings per share from continuing operations moved to US$0.12 from US$0.16. Alongside these mixed results, the company issued third-quarter 2026 revenue guidance of US$265 million to US$295 million, giving investors fresh insight into how management sees near-term demand and profitability...
NYSE:WRBY
NYSE:WRBYSpecialty Retail

Warby Parker Stock And Other Importers Tied To $100b Tariff Refunds

Tariff refunds worth US$100b are set to flow back to US importers and retailers after a Supreme Court ruling wiped out a key set of Trump era emergency tariffs. That kind of cash reshuffle can change how certain stocks behave and how investors think about them. This article walks through three stocks exposed to the news and explains why their next moves could matter for your portfolio. The stocks covered below are just a starting sample, and the full screen surfaced 11 more US importers and...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

Does NextDecade's Wider Loss and ESOP Shelf Reframe the LNG Build-Out Story for NEXT?

In the second quarter of 2026, NextDecade Corporation reported a higher net loss of US$65.43 million and increased loss per share, and also filed a US$31.70 million shelf registration for up to 5,000,000 shares of common stock under an ESOP-related offering. The combination of widening losses over the first half of 2026 and a new equity shelf highlights how NextDecade is balancing capital needs for its LNG build-out with the risk of additional shareholder dilution. We’ll now examine how the...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Higher Rates Could Lift These US Bank And Financial Services Stocks

With PCE inflation holding above 2% for years and traders now bracing for possible Fed rate hikes into 2027, the cost of money is back in the spotlight. That creates both potential winners and losers across US banks and financial services stocks exposed to this policy shift. This article walks through three stocks from the screener that appear positioned to benefit and explains what their profiles might mean for your portfolio decisions. The three stocks highlighted below are only a sample...
NYSE:KMX
NYSE:KMXSpecialty Retail

Is CarMax (KMX) Fully Valued On Its Executive Change?

Executive change puts CarMax stock in focus CarMax (KMX) is back on investors' radar after the company announced that Executive Vice President and Chief Innovation and People Officer Diane Cafritz will leave at the end of 2026, with a short consulting period extending into mid 2027. See our latest analysis for CarMax. The leadership update lands at a time when CarMax’s share price has been strong over shorter periods, with a 30 day share price return of 8.77% and a 90 day share price return...
NYSE:ESAB
NYSE:ESABMachinery

Will Record Sales, Eddyfi Deal and Raised 2026 Outlook Change ESAB's (ESAB) Margin Narrative?

ESAB Corporation recently reported its second-quarter 2026 results, with sales rising to US$807.63 million from US$715.59 million a year earlier, while net income fell to US$32.35 million from US$66.88 million. Alongside record sales and an earnings miss, ESAB closed the Eddyfi acquisition ahead of schedule and raised its 2026 outlook, tying short-term margin pressure to what management describes as stronger long-term demand and expanded technology capabilities. We’ll now examine how ESAB’s...
NYSE:TTI
NYSE:TTIEnergy Services

TETRA Technologies (TTI) Could Be 32% Below Fair Value After Arkansas Bromine Approval

Why the latest earnings matter for TETRA Technologies stock TETRA Technologies (TTI) has become a focus for investors after its second quarter earnings on 3 August 2026, which paired revenue and EBITDA growth with a final go ahead for the Arkansas bromine project. See our latest analysis for TETRA Technologies. Over the past year TETRA Technologies has delivered a very strong 1 year total shareholder return of 117.09%. However, the share price is down 16.40% over 3 months and 9.95% over 30...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Selective Insurance Group (SIGI) Leans On Efficiency Story, Does It Look Fairly Valued?

Why Selective Insurance Group Is On Investor Radar Today Selective Insurance Group (SIGI) is drawing investor attention after recent trading put its shares around $96.23, with performance figures available for the past week, month, past 3 months, year to date, and 1 year. See our latest analysis for Selective Insurance Group. Recent trading puts Selective Insurance Group’s share price at $96.23, with a 12.04% 90 day share price return and a 26.54% 1 year total shareholder return. This may...